rs121913377, BRAF

N. diseases: 480
Disease: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
CUI: C0278851
Disease: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
0.040 GeneticVariation BEFREE We did an open-label, non-randomised, phase 2 trial at ten academic centres and hospitals worldwide in patients aged 18 years or older with histologically confirmed recurrent or metastatic papillary thyroid cancer refractory to radioactive iodine and positive for the BRAF(V600E) mutation. 27460442 2016
Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
CUI: C0278851
Disease: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
0.040 GeneticVariation BEFREE Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma. 26795218 2016
Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
CUI: C0278851
Disease: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
0.040 GeneticVariation BEFREE Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib. 25549723 2015
Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
CUI: C0278851
Disease: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
0.040 GeneticVariation BEFREE Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation. 23489023 2013